Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
148.4 USD | -0.61% | +1.09% | -5.31% |
01:06pm | J&J: encouraging results in prostate cancer | CF |
12:26pm | J&J: positive results in bladder cancer | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.31% | 359B | |
+31.47% | 662B | |
+21.96% | 546B | |
+16.94% | 323B | |
+4.67% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+4.26% | 167B | |
-1.89% | 157B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- SVB Securities Adjusts Price Target on Johnson & Johnson to $194 From $200, Keeps Outperform Rating